INFORMED, which stands for Information Exchange and Data Transformation, will investigate the best ways to integrate data science into regulatory decision-making, with an initial focus on digital health and advanced analytics related to cancer.
Here are three initial projects under the INFORMED umbrella.
1. A collaboration with Project Data Sphere, a nonprofit open-access cancer data repository, to develop algorithms that use medical imaging data to classify tumor dynamics.
2. A joint fellowship program with the National Cancer Institute at the National Institutes of Health to develop digital biomarkers as drug development tools.
3. A fellowship program with Cambridge, Mass.-based Harvard University focused on developing and implementing artificial intelligence and machine learning algorithms for regulatory science applications.
More articles on supply chain:
Commissioner Dr. Scott Gottlieb says FDA is ‘actively developing’ regulatory framework for AI technologies
McKesson adds Medtronic exec as independent director: 4 takeaways
FDA approves first drug for rare form of rickets: 3 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.